These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 35536069

  • 41. Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats.
    Ji C, Li Y, Mo Y, Lu Z, Lu F, Lin Q, Liu X, Zou C, Wu Y.
    Front Pharmacol; 2021; 12():780924. PubMed ID: 34966280
    [Abstract] [Full Text] [Related]

  • 42. Association between decreased thyroid stimulating hormone and hyperuricemia in type 2 diabetic patients with early-stage diabetic kidney disease.
    Feng X, Huang J, Peng Y, Xu Y.
    BMC Endocr Disord; 2021 Jan 06; 21(1):1. PubMed ID: 33407357
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A, Liu G, Zhong X, Hu S, Ma R, Gou L, Zafar MI, Chen L.
    Med Sci Monit; 2019 Mar 05; 25():1699-1708. PubMed ID: 30835718
    [Abstract] [Full Text] [Related]

  • 44. The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus.
    Dong Z, Liang Z, Guo M, Hu S, Shen Z, Hai X.
    Dis Markers; 2018 Mar 05; 2018():1578320. PubMed ID: 30159101
    [Abstract] [Full Text] [Related]

  • 45. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
    Wang Y, Peng W, Zhang X, Qiao H, Wang L, Xu Z, Wu C.
    J Renin Angiotensin Aldosterone Syst; 2016 Jul 05; 17(3):. PubMed ID: 27638852
    [Abstract] [Full Text] [Related]

  • 46. Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease.
    Zhang H, Hu W, Zhang G.
    Int Urol Nephrol; 2020 Aug 05; 52(8):1517-1522. PubMed ID: 32458209
    [Abstract] [Full Text] [Related]

  • 47. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop.
    Zhou Y, Ma XY, Han JY, Yang M, Lv C, Shao Y, Wang YL, Kang JY, Wang QY.
    World J Diabetes; 2021 Jan 15; 12(1):19-46. PubMed ID: 33520106
    [Abstract] [Full Text] [Related]

  • 48. Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR.
    Lai Y, Tang H, Zhang X, Zhou Z, Zhou M, Hu Z, Zhu F, Zhang L, Nie J.
    Kidney Blood Press Res; 2022 Jan 15; 47(1):61-71. PubMed ID: 34788763
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
    Zhou J, Wang D, Li B, Li X, Lai X, Lei S, Li N, Zhang X.
    Kidney Blood Press Res; 2021 Jan 15; 46(4):421-432. PubMed ID: 34233325
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease.
    Chen R, Zhu D, Yang R, Wu Z, Xu N, Chen F, Zhang S, Chen H, Li M, Hou K.
    Ann Transl Med; 2022 Jul 15; 10(13):750. PubMed ID: 35957707
    [Abstract] [Full Text] [Related]

  • 54. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, Kornak J, Grimes B, Dwyer T, Chassy AW, Fiehn O.
    J Ren Nutr; 2015 Jul 15; 25(4):351-6. PubMed ID: 25802017
    [Abstract] [Full Text] [Related]

  • 55. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P.
    PLoS One; 2016 Jul 15; 11(1):e0141738. PubMed ID: 26751065
    [Abstract] [Full Text] [Related]

  • 56. Urinary Microvesicle-Bound Uromodulin: A Potential Molecular Biomarker in Diabetic Kidney Disease.
    Lou NJ, Ni YH, Jia HY, Deng JT, Jiang L, Zheng FJ, Sun AL.
    J Diabetes Res; 2017 Jul 15; 2017():3918681. PubMed ID: 28182086
    [Abstract] [Full Text] [Related]

  • 57. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC, Croyal M, Ene L, Aguesse A, Billon-Crossouard S, Krempf M, Lemoine S, Guebre-Egziabher F, Juillard L, Soulage CO.
    Toxins (Basel); 2019 Nov 01; 11(11):. PubMed ID: 31683880
    [Abstract] [Full Text] [Related]

  • 58. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
    Gupta N, Buffa JA, Roberts AB, Sangwan N, Skye SM, Li L, Ho KJ, Varga J, DiDonato JA, Tang WHW, Hazen SL.
    Arterioscler Thromb Vasc Biol; 2020 May 01; 40(5):1239-1255. PubMed ID: 32212854
    [Abstract] [Full Text] [Related]

  • 59. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
    Shao Y, Lv C, Yuan Q, Wang Q.
    J Diabetes Res; 2016 May 01; 2016():1925424. PubMed ID: 27069929
    [Abstract] [Full Text] [Related]

  • 60. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
    Carpes LS, Nicoletto BB, Canani LH, Rheinhemer J, Crispim D, Souza GC.
    PLoS One; 2021 May 01; 16(6):e0253501. PubMed ID: 34170951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.